These stocks offer high yields, are big names in their respective sectors, and have strong fundamentals.
Shares of Pfizer Inc. PFE slipped 1.19% to $24.08 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.79% to 7,499.36 and the ...
1don MSNOpinion
Why Pfizer could prove to be an underrated GLP-1 stock
It could prove to be a case of better later than never for the healthcare giant.
I keep buying Pfizer (NYSE:PFE | PFE Price Prediction) every time my brokerage cash builds up, and I am not slowing down. The ...
Savvy investors know that change creates opportunities. And a major change is underway at the nation's central bank. Kevin ...
Things are going from bad to worse for the pharmaceutical giant.
Pfizer (NYSE: PFE) is a high-yielding stock that's trading at a low valuation. The problem is, it's been that way for some time now. The stock's lack of movement in one direction or another seems to ...
Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are up 14% to $68 and change in afternoon trading Friday, extending a ...
Pfizer is struggling right now, leaving it in the Wall Street doghouse; it won't be there forever.
Pfizer (PFE) stock drops 3% as CFO Dave Denton reveals August exit. Cecile Guegan appointed interim CFO while company ...
Pfizer (PFE) stock drops as CFO Dave Denton will resign Aug. 15; Cecile Guegan is named interim CFO as the company launches ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results